Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
Open Access
- 11 September 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (9), 685
- https://doi.org/10.3390/diagnostics10090685
Abstract
Both perfusion-weighted imaging (PWI) measures and serum neurofilament light (sNfL) chain levels have been independently associated with disability in multiple sclerosis (MS) patients. This study aimed to determine whether these measures are correlated to each other or independently describe different MS processes. For this purpose, 3T MRI dynamic susceptibility contrast (DSC)–PWI and single-molecule assay (Simoa)-based sNfL methods were utilized when investigating 86 MS patients. The perfusion measures of mean transit time (MTT), cerebral blood volume (CBV), and cerebral blood flow (CBF) were derived for the normal-appearing whole brain (NAWB), the normal-appearing white matter (NAWM), the gray matter (GM), the deep GM (DGM), and the thalamus. The normalized CBV and CBF (nCBV and nCBV) were calculated by dividing by the corresponding NAWM measure. Age- and sex-adjusted linear regression models were used to determine associations between the DSC–PWI and sNfL results. False discovery rate (FDR)-adjusted p-values < 0.05 were considered statistically significant. A greater age and thalamic MTT were independently associated with higher sNfL levels (p < 0.001 and p = 0.011) and explained 36.9% of sNfL level variance. NAWM MTT association with sNfL levels did not survive the FDR correction. In similar models, a lower thalamic nCBF and nCBV were both associated with greater sNfL levels (p < 0.001 and p = 0.022), explaining 37.8% and 44.7% of the variance, respectively. In conclusion, higher sNfL levels were associated with lower thalamic perfusion.This publication has 29 references indexed in Scilit:
- Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patientsMultiple Sclerosis Journal, 2016
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routineExpert Review of Neurotherapeutics, 2016
- Body fluid biomarkers in multiple sclerosisThe Lancet Neurology, 2014
- Cerebral Arterial Bolus Arrival Time is Prolonged in Multiple Sclerosis and Associated with DisabilityJournal of Cerebral Blood Flow & Metabolism, 2013
- Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosisMultiple Sclerosis Journal, 2013
- Brain Hemodynamic Changes Associated with Chronic Cerebrospinal Venous Insufficiency Are Not Specific to Multiple Sclerosis and Do Not Increase Its SeverityRadiology, 2012
- The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosisHuman Brain Mapping, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Abnormalities of cerebral perfusion in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Rating neurologic impairment in multiple sclerosisNeurology, 1983